Xeris Biopharma Holdings: Looking For More Growth In Q1 Earnings

Group 1 - The article discusses the potential for Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) to make significant upward movements in its stock price, indicating a positive outlook for the company [1] - The author has a long position in XERS shares, suggesting confidence in the company's future performance [2] - The author emphasizes a focus on innovative companies in the biotech sector that are developing breakthrough therapies and pharmaceuticals, which aligns with Xeris Biopharma's business model [1]